SEARCH

SEARCH BY CITATION

References

  • 1
    Hardy RR & Hayakawa K. CD5 B cells, a fetal B cell lineage. Adv Immunol 1994; 55:297 339.
  • 2
    Hardy RR & Hayakawa K. A developmental switch in B lymphopoiesis. Proc Natl Acad Sci USA 1991; 88:11550 4.
  • 3
    Karras JG, Wang Z, Huo L, Howard RG, Frank DA, Rothstein TL. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J Exp Med 1997; 185:1035 42.
  • 4
    Wortis HH. Surface markers, heavy chain sequences, and B cell lineages. Int Rev Immunol 1992; 8:235 46.
  • 5
    Stall AM, Wells SM, Lam K-P. B-1 cells: unique origins and functions. Semin Immunol 1996; 8:45 59.DOI: 10.1006/smim.1996.0007
  • 6
    Anderson U, Bird AG, Britton BS, Palacios R. Humoral and cellular immunity in humans studied at the cell level. Immunol Rev 1981; 57:1 38.
  • 7
    Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kishimoto T. Rheumatoid factor secretion from human Leu-1+ B cells. Science 1987; 236:81 3.
  • 8
    Bhat NM, Kantor AB, Bieber MM, Stall AM, Herzenberg LA, Teng NNH. The ontogeny and functional characteristics of human B-1 (CD5+) B cells . Int Immunol 1992; 4:243 52.
  • 9
    Parker DC, Wadsworth DC, Schneider GB. Activation of murine B lymphocytes by anti-immunoglobulin is an inductive signal leading to immunoglobulin secretion. J Exp Med 1980; 152:138 51.
  • 10
    Tony HP, Phillips NE, Parker DC. Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell–B cell interactions. J Exp Med 1985; 162:1695 708.
  • 11
    Wortis HH, Teutsch M, Higer M, Zheng J, Parker DC. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc Natl Acad Sci USA 1995; 92:3348 52.
  • 12
    Wheeler K & Gordon J. Co-ligation of surface IgM and CD40 on naïve B lymphocytes generates a blast population with an ambiguous extrafollicular/germinal centre cell phenotype. Int Immunol 1996; 8:815 28.
  • 13
    Miller RA & Gralow J. The induction of leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA). J Immunol 1984; 133:3408 14.
  • 14
    Morikawa K, Oseko F, Morikawa S. Induction of CD5 antigen on human CD5- B cells by stimulation with Staphyloccocus aureus Cowan strain I. Int Immunol 1993; 5:809 16.
  • 15
    Vernino L, Pisetsky DS, Lipsky PE. Analysis of the expression of CD5 by human B cells and correlation with functional activity. Cell Immunol 1992; 139:185 97.
  • 16
    Defrance T, Vanbervliet B, Durand I, Banchereau J. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells. Eur J Immunol 1989; 19:293 9.
  • 17
    Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 cells. Science 1996; 274:1906 9.DOI: 10.1126/science.274.5294.1906
  • 18
    Gagro A & Gordon J. The interplay between T helper subset cytokines and IL-12 in directing human B lymphocyte differentiation. Eur J Immunol 1999; 29:3369 79.DOI: 10.1002/(sici)1521-4141(199910)29:10<3369::aid-immu3369>3.0.co;2-#
  • 19
    Gagro A & Rabatic S. Allergen-induced CD23 on CD4+ T lymphocytes and CD21 on B lymphocytes in patients with allergic asthma: evidence and regulation. Eur J Immunol 1994; 24:1109 14.
  • 20
    Caligaris-Cappio F & Janossy G. Surface markers in chronic lymphoid leukemias of B cell type. Semin Hematol 1985; 22:1 15.
  • 21
    Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L, Mehta K. Human CD38: a glycoprotein in a search of a function. Immunol Today 1994; 15:95 7.
  • 22
    Macardle PJ, Weedon H, Fusco M, Nobbs S, Ridings J, Flego L, Roberton DM, Zola H. The antigen receptor complex on cord B lymphocytes. Immunology 1997; 90:376 82.
  • 23
    Tucci A, Mouzaki A, James H, Bonnefoy J-Y, Zubler RH. Are cord blood B cells functionally mature? Clin Exp Immunol 1991; 84:389 94.
  • 24
    Holder MJ, Abbot SD, Milner AE, Gregory CD, Casamayor M, Johnson GD, MacLennan ICM, Gordon J. Interleukin-2 expands and maintains IgM plasmablasts from a CD5+ subset contained within the germinal center cell-enriched (surface IgD /CD39 buoyant) fraction of human tonsil. Int Immunol 1993; 5:1059 66.
  • 25
    Butcher RD, McGarvie GM, Cushley W. Recombinant interleukin-4 promotes expression of the CD25 (Tac) antigen at the plasma membrane of high-density human tonsillar B lymphocytes. Immunology 1990; 69:57 64.
  • 26
    Dono M, Burgio VL, Tacchetti C et al. Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization. Eur J Immunol 1996; 26:2035 42.
  • 27
    Galibert L, Burdin N, De Saint-Vis B, Garrone P, Van Kooten C, Banchereau J, Rousset F. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J Exp Med 1996; 183:77 85.
  • 28
    Gordon J, Cairns JA, Liu Y-J, Flores-Romo L, MacLennan ICM, Jansen KU, Bonnefoy J-Y. Role of membrane and soluble CD23 in lymphocyte physiology. Monogr Allergy 1991; 29:156 68.
  • 29
    Jamin C, Le Corre R, Lydyard PM, Youinou P. Anti-CD5 extends the proliferative response of human CD5+ B cells activated with anti-IgM and interleukin-2. Eur J Immunol 1996; 26:57 62.
  • 30
    Youinou P, Jamin C, Lydyard PM. CD5 expression in human B-cell populations. Immunol Today 1999; 20:312 6.DOI: 10.1016/s0167-5699(99)01476-0
  • 31
    McCloskey N, Pound JD, Holder MJ, Williams JM, Roberts LM, Lord JM, Gordon J. The extrafollicular-to-follicular transition of human B lymphocytes: induction of functional globotriaosylceramide (CD77) on high threshold occupancy of CD40. Eur J Immunol 1999; 29:3236 44.DOI: 10.1002/(sici)1521-4141(199910)29:10<3236::aid-immu3236>3.0.co;2-t
  • 32
    Linton P-J, Lo D, Lai L, Thorbecke GJ, Klinman NR. Among naı¨ve precursor cell subpopulations only progenitors of memory B cells originate germinal centres. Eur J Immunol 1992; 22:1293 7.
  • 33
    Caligaris-Cappio F, Riva M, Tesio L, Schena M, Gaidano G, Begui L. Human normal CD5+ B lymphocytes can be induced to differentiate to CD5 B lymphocytes with germinal center cell features. Blood 1989; 73:1259 63.
  • 34
    Arnold LW, McCray SK, Tatu C, Clarke SH. Identification of a precursor to phosphatidylcholine-specific B-1 cells suggesting that B-1 cells differentiate from splenic conventional B cells in vivo: cyclosporin A blocks differentiation to B-1 . J Immunol 2000; 164:2924 30.
  • 35
    Sen G, Bikah G, Venkatamaran C, Bondada S. Negative regulation of antigen receptor-mediated signalling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur J Immunol 1999; 29:3319 28.DOI: 10.1002/(sici)1521-4141(199910)29:10<3319::aid-immu3319>3.0.co;2-9
  • 36
    Pers JO, Jamin C, Le Corre R, Lydyard PM, Youinou P. Ligation of CD5 on resting B cells, but not on resting T cells, results in apoptosis. Eur J Immunol 1998; 28:4170 6.DOI: 10.1002/(sici)1521-4141(199812)28:12<4170::aid-immu4170>3.0.co;2-o
  • 37
    Van de Velde HI, Von Hoegen W, Luo W, Parnes JR, Thielemans K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 1991; 351:662 5.
  • 38
    Biancone L, Bowen MA, Lim A, Aruffo A, Andres G, Stamenkovic I. Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. J Exp Med 1996; 184:811 9.
  • 39
    Pospisil R, Fitts MG, Mage RG. CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences. J Exp Med 1996; 184:1279 84.
  • 40
    Hippen K, Tze LE, Behrens TW. CD5 maintains tolerance in anergic cells. J Exp Med 2000; 191:883 9.